Literature DB >> 9383734

Level A in vivo-in vitro correlation: nonlinear models and statistical methodology.

A Dunne1, T O'Hara, J Devane.   

Abstract

Some new nonlinear models for the relationship between the fraction of drug dose dissolved (absorbed) in vivo and that dissolved in vitro are described. The models are empirical in nature and are generalizations of the linear model that, at present, is the most commonly used model. The modeling approach is based on considering the time at which a drug molecule goes into solution (in vitro or in vivo) to be a random variable and relating the distribution functions using proportional odds, proportional hazards, and proportional reversed hazards models. The models are further extended by allowing the parameter that relates in vivo and in vitro to be a function of time. A statistical model for the data is developed and used as the basis for a statistical methodology for fitting these models. The methods are shown to be generalized linear mixed effects model (GLMM) methods. The models are fitted to some data sets, and the results demonstrate that these models have potential.

Mesh:

Year:  1997        PMID: 9383734     DOI: 10.1021/js970155d

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Does the dose-solubility ratio affect the mean dissolution time of drugs?

Authors:  P Lánský; M Weiss
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  In vivo-in vitro correlation (IVIVC) modeling incorporating a convolution step.

Authors:  T O'Hara; S Hayes; J Davis; J Devane; T Smart; A Dunne
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-06       Impact factor: 2.745

3.  A time scaling approach to develop an in vitro-in vivo correlation (IVIVC) model using a convolution-based technique.

Authors:  Cian Costello; Stefaan Rossenu; An Vermeulen; Adriaan Cleton; Adrian Dunne
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-07-07       Impact factor: 2.745

4.  Hydrogel-based matrices for controlled drug delivery of etamsylate: Prediction of in-vivo plasma profiles.

Authors:  Soha M El-Masry; Sally A Helmy
Journal:  Saudi Pharm J       Date:  2020-11-06       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.